David Willman – Page 2 – Alliance for Human Research Protection

September 19, 2006

NIH A House of Ill Repute–Scientists for Sale While on Gov Payroll

During the Reagan era, the National Institutes of Health (NIH) was described by (then) Secretary of Health

NIH A House of Ill Repute–Scientists for Sale While on Gov Payroll

September 11, 2006

NIH Calls it “Serious Miscondcut” Yet Agency Takes No Disciplinary actions_LA Times

The LA Times notes that "U.S. conflict-of-interest law prohibits a federal employee from representing an outside party

NIH Calls it “Serious Miscondcut” Yet Agency Takes No Disciplinary actions_LA Times

August 11, 2006

Congress to Probe NIH Conflict of Interest Policies

NIH officials have yet to do something about NIH scientists’ conflicts of interest. Following the latest revelations

Congress to Probe NIH Conflict of Interest Policies

July 17, 2006

LAT Investigation: NIH Scientist Ties to Pharma

U.S. Taxpayers provide $28 billion to support NIH research, and though NIH scientists are the highest paid

LAT Investigation: NIH Scientist Ties to Pharma

June 14, 2006

Chief NIH Geriatric Psychiatrist Takes the Fifth Refusing toTestify about Tissues Sent to Pfizer

The House Energy and Commerce investigative report is an indictment of the NIH and its lack of

Chief NIH Geriatric Psychiatrist Takes the Fifth Refusing toTestify about Tissues Sent to Pfizer

July 14, 2005

Internal Investigation Found Widespread Ethical Lapses by NIH Scientists

Internal Investigation Found Widespread Ethical Lapses by NIH Scientists Thu, 14 Jul 2005 In a letter to

Internal Investigation Found Widespread Ethical Lapses by NIH Scientists

March 10, 2005

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT Thu, 10 Mar 2005 The Los

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT

March 3, 2005

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ

February 1, 2005

NIH to Ban Consulting Deals With Drug Firms – LAT / NYT

NIH to Ban Consulting Deals With Drug Firms – LAT / NYT Tue, 1 Feb 2005 Thanks

NIH to Ban Consulting Deals With Drug Firms – LAT / NYT

May 18, 2004

NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling – LA Times

LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer

NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling – LA Times

March 2, 2004

Ethics Policy Announced for NIH Officials – LAT

Ethics Policy Announced for NIH Officials – LAT Tue, 2 Mar 2004 This is a case demonstrating

Ethics Policy Announced for NIH Officials – LAT

December 7, 2003

Double Dipping at NIH: "the Gaming Must End" – Editorial WashPost

Double Dipping at NIH: “the Gaming Must End” – Editorial WashPost Tue, 6 Jul 2004 Monday’s Washington

Double Dipping at NIH: "the Gaming Must End" – Editorial WashPost

December 7, 2003

NIH Expert on Safe Drug Research Seeks Whistleblower Protection

NIH Expert on Safe Drug Research Seeks Whistleblower Protection Tue, 14 Dec 2004 In the wake of

NIH Expert on Safe Drug Research Seeks Whistleblower Protection

December 7, 2003

Stealth Merger: Drug Companies and Medical Research at NIH – LAT

Stealth Merger: Drug Companies and Medical Research at NIH – LAT Sun, 7 Dec 2003 Los Angeles

Stealth Merger: Drug Companies and Medical Research at NIH – LAT

Load More Articles

ALLIANCE FOR HUMAN RESEARCH PROTECTION

NIH A House of Ill Repute–Scientists for Sale While on Gov Payroll

NIH Calls it “Serious Miscondcut” Yet Agency Takes No Disciplinary actions_LA Times

Congress to Probe NIH Conflict of Interest Policies

LAT Investigation: NIH Scientist Ties to Pharma

Chief NIH Geriatric Psychiatrist Takes the Fifth Refusing toTestify about Tissues Sent to Pfizer

Internal Investigation Found Widespread Ethical Lapses by NIH Scientists

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ

NIH to Ban Consulting Deals With Drug Firms – LAT / NYT

NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling – LA Times

Ethics Policy Announced for NIH Officials – LAT

Double Dipping at NIH: "the Gaming Must End" – Editorial WashPost

NIH Expert on Safe Drug Research Seeks Whistleblower Protection

Stealth Merger: Drug Companies and Medical Research at NIH – LAT

Subscribe to Our Newsletter!